We have to weave biology & technology into the DNA of U.S. national security.

B.Next will demonstrate the power of technologies to identify and quench infectious disease outbreaks.

Why Now?

The convergence of the digital world with biology is creating new opportunities.

Why B.Next?

Uniquely positioned at the intersection of innovation, entrepreneurship, and government, B.Next explores the art of the possible for biodefense.

B.Next, an IQT lab, illuminates the national security implications of infectious disease outbreaks through thought leadership, proof-of-concept experimentation, and informing IQT investment strategy. We are building a trusted network linking government, academia, civil society, and private sector innovators.

Articles Feed - Homepage

Precision Medicine 101

This white paper covers precision medicine 101 and explores the aspirations to develop medical treatments to the individual character of each patient, applications and future directions, and precision medicine in China.

Read More

Publication

Rapid Expert Consultation on Crisis Standards of Care for the COVID-19 Pandemic

In response to a request from the Office of Science and Technology Policy (OSTP), the National Academies of Sciences, Engineering, and Medicine convened a standing committee of experts to help inform OSTP on critical science and policy issues related to emerging infectious diseases and other public health threats. The standing committee includes members with expertise in emerging infectious diseases, public health, public health preparedness and response, biological sciences, clinical care and crisis standards of care, risk communication, and regulatory issues. This publication, co-authored by B.Next’s Dr. Dan Hanfling, articulates the guiding principles, key elements, and core messages that undergird Crisis Standards of Care decision-making at all levels.

Read More

Publication